Royalty Pharma: Q1 Earnings Snapshot

Published: 2026-05-06 07:30:19 ET RPRX

Published on 05/06/2026 at 07:30 am EDT

NEW YORK (AP) — NEW YORK (AP) — Royalty Pharma (RPRX) on Wednesday reported first-quarter profit of $295 million.

On a per-share basis, the New York-based company said it had profit of 53 cents. Earnings, adjusted for non-recurring costs, were $1.30 per share.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of $1.22 per share.

The company posted revenue of $631 million in the period. Its adjusted revenue was $925 million.

Royalty Pharma expects full-year revenue in the range of $3.33 billion to $3.45 billion.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RPRX at https://www.zacks.com/ap/RPRX

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News